NIH-funded research R03 grant

Using topical treatments to improve healing of chronic wounds

Official title: Topical Senolytics for Chronic Wound Healing

Funded at Mayo Clinic Rochester · NIH-10725252 · Data updated 2026-11-12

This study is looking at a new treatment to help older adults with chronic wounds, like those caused by diabetes, heal better by using special creams that target and remove stubborn cells that slow down healing.

More Wound research and trials

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startAugust 15, 2023
Project endAugust 14, 2026
Funding year2023
Award (this year)$322,800
NIH project number1R03AG082919-01
Project IDNIH-10725252 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are elderly individuals with chronic non-healing wounds, particularly those related to diabetes.

Less likely to help

Patients with acute wounds or those not experiencing chronic wound issues may not benefit from this research.

What this research studies

This research investigates the use of topical senolytic agents to enhance the healing of chronic wounds, particularly in elderly patients suffering from conditions like diabetes. By targeting and eliminating senescent cells that hinder the healing process, the study aims to improve wound recovery outcomes. The researchers have developed prototype senolytic agents that have shown promise in laboratory settings, and they will further explore their effectiveness in a controlled clinical environment. The approach involves understanding the specific types of senescent cells present in chronic wounds and how they contribute to delayed healing.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for chronic wounds, significantly improving healing times and quality of life for patients.

How similar studies have gone: While the concept of targeting senescent cells is relatively novel, preliminary studies have shown promise in similar approaches for improving wound healing.

Where this research is happening

  • Mayo Clinic Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Wyles, Saranya Purushothaman — Mayo Clinic Rochester
  • Study coordinator: Wyles, Saranya Purushothaman

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.